Rare diseases
Investigational molecules
Locations
Back to Germany1 819 clinical trials in Potsdam, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Phase 2b Randomized Study of Semaglutide Subcutaneous Depot for Weight Reduction in Adults with Obesity or Overweight
GermanyStudy of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control
GermanyStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
GermanyEfficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes
GermanyFirst‑line Study of RMC‑9805 with Investigator’s Choice Chemotherapy Drug Combination vs Chemotherapy Alone in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Adenocarcinoma
GermanyAzenosertib versus drug combination in platinum‑resistant high‑grade serous ovarian, fallopian tube or primary peritoneal cancer
GermanyPhase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)
GermanyA study of SAR448851 with florquinitau (18F) to assess safety and effectiveness in early Alzheimer’s disease
GermanyPhase 3 Study of Romiplostim Combined with Prednisolone versus Prednisolone Alone in Adults with Previously Untreated Primary Immune Thrombocytopenia (ITP)
GermanyStudy of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy
GermanyEvaluation of zongertinib, fulvestrant and goserelin acetate in patients with HR‑positive HER2‑negative advanced breast cancer
GermanyRandomized trial of irinotecan drug combination versus standard therapy as first-line treatment in patients with locally advanced or metastatic small bowel adenocarcinoma
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on breast cancer treatments, including studies for triple-negative, HER2-positive, and hormone receptor-positive variants. Research encompasses new combination therapies and targeted treatments.
Multiple studies are evaluating novel drug combinations and personalized therapeutic approaches.
Clinical research targeting various skin conditions, including atopic dermatitis and chronic skin disorders. Studies focus on both topical and systemic treatments.
Investigations include both traditional and innovative therapeutic approaches for skin conditions.
Studies focusing on multiple sclerosis treatment options, evaluating new medications and comparing their effectiveness to existing therapies.
Research aims to improve treatment outcomes and quality of life for patients with neurological conditions.
Research focusing on cardiovascular disease management and innovative treatments for related conditions, including studies on lipid management.
Trials aim to reduce major cardiovascular events and improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
